JG
Jared Gollob (Chief Medical Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Kymera Therapeutics, Inc. (KYMR). The largest single filing was $4.4M of KYMR (49,307 sh across 6 lots, as filed), executed Dec 8 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$5.1M
shares × price, as filed
Last traded
Mar 4
Filed Mar 4
Median ADV $102.3M across their filed names
Open performance→Volume by month
Buys $0
Sells $9.1M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
KYMRRecent filings
KYMRSALE
Kymera Therapeutics, Inc.
View filing →
$743K8,514 sh across 4 lots
Exec Mar 2
Filed Mar 4 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. View filing → $4.4M
49,307 sh across 6 lots
Exec Dec 8 2025
Filed Dec 8 2025 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. View filing → $3.7M
59,576 sh across 4 lots
Exec Oct 15 2025
Filed Oct 15 2025 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. View filing → $187K
3,114 sh × $60.00
Exec Oct 13 2025
Filed Oct 14 2025 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. View filing → $142K
4,695 sh × $30.33
Exec Mar 3 2025
Filed Mar 3 2025 · 5:30 PM ET